XML 46 R37.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders' Equity (Details) - USD ($)
 1 Months Ended 6 Months Ended 12 Months Ended
Apr. 29, 2020
Apr. 29, 2019
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Mar. 29, 2022
Mar. 21, 2022
Stockholders' Equity (Details) [Line Items]              
Common stock outstanding             $ 1,750,000
Stock repurchase (in Shares)     110,000        
Total unrecognized compensation expense     $ 479,162        
Weighted average period     3 years 6 months 7 days        
Aggregate intrinsic value of stock options, outstanding     $ 45,840 $ 258,359      
Aggregate intrinsic value of stock options, exercisable     $ 38,340 159,558      
Purchase an aggregate of common stock (in Shares)     24,000        
Exercise price of common stock (in Dollars per share)     $ 2.66        
Stock options, term     10 years        
Purchase an aggregate of shares to common stock (in Shares)     224,500        
Exercise price (in Dollars per share)     $ 2.66        
Aggregate fair value of options granted     $ 636,957 $ 78,522      
Repurchased shares of common stock $ 9,950 $ 500,000          
Repurchase plan expires date   Apr. 29, 2020          
Net share exercise (in Shares)         22,013    
Outstanding common stock           $ 1,750,000  
Common stock, treasury shares (in Shares)     141,963   31,963    
Treasury Shares [Member]              
Stockholders' Equity (Details) [Line Items]              
Stock repurchase (in Shares)     110,000        
2011 Plan [Member]              
Stockholders' Equity (Details) [Line Items]              
Number of shares issued under plan (in Shares)     36,402        
2016 Plan [Member]              
Stockholders' Equity (Details) [Line Items]              
Number of shares issued under plan (in Shares)     1,300,000        
Percentage of common stock delivered pursuant to incentive stock options     100.00%        
Number of stock available for future issuance (in Shares)     767,728